KASALYN THUVAMONTOLRAT: Open Payments
NPI 1396282711 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,968 in 158 payments from 26 companies in 2025. Trend: 2023 $2,146 · 2024 $3,908 · 2025 $3,968
Food & beverage: $3,968
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 27 | $712 |
| ABBVIE INC. | 27 | $597 |
| Teva Pharmaceuticals USA, Inc. | 8 | $323 |
| Eisai Inc. | 11 | $295 |
| PFIZER INC. | 12 | $274 |
| Amneal Pharmaceuticals LLC | 11 | $264 |
| Lundbeck LLC | 9 | $228 |
| ACADIA Pharmaceuticals Inc | 5 | $135 |
| Axsome Therapeutics, Inc. | 6 | $127 |
| Biogen, Inc. | 5 | $126 |
Products named: QULIPTA, AUSTEDO XR, Fintepla, Leqembi, NURTEC ODT, CREXONT, VYEPTI, Nayzilam.
Industry payments across CA — which companies pay providers there.
